General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data
Besides, it is also used for diarrhea, cystic fibrosis, obesity, lung cancer, and many other conditions
S.GaryE
Proc Natl Acad Sci USA 1995
let absorb before styling Injectable form (requires prescription, available through licensed compounding pharmacies): Injectable GHK-Cu is used in clinical protocols for broader anti-aging and tissue repair applications
Increase activity of superoxide dismutase (SOD) is shown in the A-GSH group.[16] T-BARS: T- Bars is a measurement of lipid peroxidation